These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2045454)

  • 21. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
    Nørgaard M; Hueg B; Staberg B
    Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.
    Herfst MJ; De Wolff FA
    Eur J Clin Pharmacol; 1982; 23(1):75-80. PubMed ID: 7128674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs.
    Bevilacqua R; Benassi CA; Schiavon O; Veronese FM
    Farmaco Sci; 1981 Jul; 36(7):598-605. PubMed ID: 7274442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
    Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
    Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin concentration of 8-methoxypsoralen, 5-methoxypsoralen and 4,5,8-trimethylpsoralen in guinea pigs.
    Park YK; Hann SK; Im S; Kim S
    J Dermatol Sci; 1993 Feb; 5(1):19-24. PubMed ID: 8485109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F; Schmuth M; Sepp N; Fritsch P
    Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for uptake of 8-methoxypsoralen and 5-methoxypsoralen by cellular nuclei.
    Sasaki M; Meguro F; Kumazawa E; Fujita H; Kakishima H; Sakata T
    Mutat Res; 1988 Jan; 197(1):51-8. PubMed ID: 3336374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of psoralen and ultraviolet A on platelet functioning: an in vitro and in vivo study.
    Procaccini EM; Pandolfi G; Monfrecola G; Rotoli B
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):4-7. PubMed ID: 1390123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice.
    Muni IA; Schneider FH; Olsson TA; King M
    Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-performance thin-layer chromatographic determination of 5-methoxypsoralen in serum from patients.
    Mignot B; Guillaume Y; Makki S; Murret E; Cavalli E; Truong TT; Thomassin M; Guinchard C
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):283-5. PubMed ID: 9390742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple and rapid determination of psoralens in topic solutions using liquid chromatography.
    Cardoso CA; Honda NK; Barison A
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):217-24. PubMed ID: 11682229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatographic determination of methoxsalen in plasma after liquid-solid extraction.
    Kucová D; Marysková D; Davídková P; Gasparic J
    J Chromatogr; 1993 May; 614(2):340-4. PubMed ID: 8314948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the skin concentrations after administration of the various phototoxic drugs.
    Park YK; Hann SK; Cho MY; Kim HJ; Shim SC; Choi SJ; Yun MH
    Yonsei Med J; 1991 Sep; 32(3):231-6. PubMed ID: 1781182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid formulations of 8-methoxypsoralen (8-MOP) and 5-MOP: a prospective double-blind crossover assessment of acute non-phototoxic adverse effects.
    George SA; Ferguson J
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):33-5. PubMed ID: 1390121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular aspects of extracorporeal photochemotherapy.
    Gasparro FP; Dall'Amico R; Goldminz D; Simmons E; Weingold D
    Yale J Biol Med; 1989; 62(6):579-93. PubMed ID: 2700057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on 8-methoxypsoralen tolbutamide interactions. 2. Studies after U.V.-A irradiation in vitro and in vivo.
    Bevilacqua R; Baccichetti F
    Farmaco; 1991 Dec; 46(12):1449-57. PubMed ID: 1821629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of food on 8-methoxypsoralen serum concentration and minimal phototoxic dose.
    Bech-Thomsen N; Angelo HR; Knudsen EA
    Br J Dermatol; 1992 Dec; 127(6):620-4. PubMed ID: 1476921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy ('Cream-PUVA').
    Martens-Lobenhoffer J; Rinke M; Lösche D; Gollnick H
    Skin Pharmacol Appl Skin Physiol; 1999; 12(5):266-70. PubMed ID: 10461095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M; Ros AM
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of 8-methoxypsoralen in mouse plasma by high performance liquid chromatography and its application to pharmacokinetic study].
    Wu TW; Cui R; Zhang BX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):792-796. PubMed ID: 30337737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.